American Regent secures rare relief in US generic drug dispute over selenious acid
New Jersey is increasingly becoming a preferred destination for Hatch-Waxman litigation. A preliminary injunction awarded to American Regent, there, could cement that status.Cipla USA, Sun Pharmaceuticals Ltd. and others have been...To view the full article, register now.
Already a subscriber? Click here to view full article